טרוויקטה - Trevicta
× ×ª×× × ×ª×¨×פ×
×××¨×©× 
| ×§×××¦× ×¤×¨××§×××××ת (ATC4) | N05AX Other antipsychotics | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ×ר××× ×¤×¢×× (ATC5) | Â
| ||||||||||||||||||
| צ×רת ××ª× | ת×× ×©×¨××¨× - I.M | ||||||||||||||||||
| צ×רת ××× ×× | EXTENDED RELEASE SUSPENSION FOR INJECTIONâ××× ×עת ××× ×× ×תר ×× ×רע×× ×ש ××××× ×ת ×תר××¤× ××ת×× ×××× ×× ××××××¥ ××¤× ×©××פ××¢ ××¢××× ×צר×× | ||||||||||||||||||
| ×ת×××× | TREVICTA, a 3 monthly injection, is indicated for the maintenance treatment of schizophrenia in adult patients who are clinically stable on 1 monthly paliperidone palmitate injectable product
| ||||||||||||||||||
| |||||||||||||||||||
| ×¢××× ×ר××¤× ××××ר×ת ××¢××× |
  | ||||||||||||||||||
| ×¢××× ×צר×× |  |
|---|
| ער××× ×××××§×רפ××× | ער××× ×§×©×ר×× ×××××§×רפ××× |
|---|---|
| ×ר××××§×× ××××ר ××©×¨× ××ר×××ת |
| ××פ×ש ×××ר×× | ×××ר×× ×-PubMed |
|---|---|
| ××××¢ ×רשת | RxList WebMD Drugs.com |
| ×©× ××¦×¨× | JANSSEN PHARMACEUTICA N.V.,BELGIUM |
| ×©× ××¢× ×ר×ש×× | J-C HEALTH CARE LTD |
| ר×ש××× | ת×ר×× ××ש×: 01/2017. ר×ש××× ×ת×ר××: 01/2017 |
| ת×ר×× ×¢×××× ××ר×× | 15/05/19 |
השינוי האחרון נעשה בֹ־12 בדצמבר 2016 ב־00:15